KYNU in macrophages contributes to the unique immune feature of LUAD via integrating single-cell and bulk RNA sequencing data: an exploratory analysis
PLOS One · 12.06.2026 · 21 (6) · e0351622
DOI: 10.1371/journal.pone.0351622 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 12.06.2026. Verfasst von Jie Yao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Macrophages, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lung adenocarcinoma (LUAD) is a predominant subtype of lung cancer associated with an unfavorable prognosis. However, the roles of the tumor microenvironment (TME) and Kynureninase (KYNU) in LUAD remain largely unclear. This study aimed to investigate the potential role of KYNU in macrophages and LUAD.
Methods
All LUAD related data were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. The expression of KYNU was analyzed across different cell types following dimensionality reduction analysis. Immune cell infiltration and immunotherapy response prediction were performed using CIBERSORT and TIMER, respectively. Gene set variation analysis (GSVA) was employed for functional enrichment.
Results
Among all immune cells in LUAD, KYNU was primarily expressed in monocytes and macrophages. The upregulated genes in KYNU+macrophages group were significantly enriched in in gene ontology (GO) terms related to antigen processing and presentation. There were increased MHC-I/ MHC-II signal interactions between KYNU+macrophages and B cells as well as T cells. In LUAD patients with higher proportions of KYNU+macrophages, a significantly greater number of patients benefited from immunotherapy ( p = 0.033). GSVA results indicated that the MHC pathway was significantly activated in high KYNU+macrophage group.
Conclusions
KYNU is primarily in LUAD macrophages, contributing to the distinct immune features and correlating with the enhanced antigen presentation in LUAD. This study preliminarily confirms that KYNU may serve as a potential biomarker for immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Thoracic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
- Department of Cardiothoracic, The Fourth Affiliated Hospital Zhejiang University School of Medicine, Yiwu, China.
- Department of Respiratory Medicine, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
ORCID-Profile: Liren Ding
Zitieren
APA
Yao, J., Zhou, C., & Ding, L. (2026). KYNU in macrophages contributes to the unique immune feature of LUAD via integrating single-cell and bulk RNA sequencing data: an exploratory analysis. PLOS One, 21(6), e0351622. https://doi.org/10.1371/journal.pone.0351622
Vancouver
Yao J, Zhou C, Ding L. KYNU in macrophages contributes to the unique immune feature of LUAD via integrating single-cell and bulk RNA sequencing data: an exploratory analysis. PLOS One. 2026;21(6):e0351622. doi:10.1371/journal.pone.0351622
BibTeX
@article{Yao2026,
author = {Yao, Jie and Zhou, Changshuai and Ding, Liren},
title = {KYNU in macrophages contributes to the unique immune feature of LUAD via integrating single-cell and bulk RNA sequencing data: an exploratory analysis},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {6},
pages = {e0351622},
doi = {10.1371/journal.pone.0351622}
}
EUVIMED